Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,285,551
-
Share change
-
-3,173,861
-
Total reported value
-
$1,376,134
-
Put/Call ratio
-
47%
-
Price per share
-
$0.26
-
Number of holders
-
33
-
Value change
-
-$3,320,148
-
Number of buys
-
11
-
Number of sells
-
29
Institutional Holders of CONATUS PHARMACEUTICALS INC - COM (CNAT) as of Q2 2019
As of 30 Jun 2019,
CONATUS PHARMACEUTICALS INC - COM (CNAT) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,285,551 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, Bank of New York Mellon Corp, Virtu Financial LLC, Parallax Volatility Advisers, L.P., BANK OF AMERICA CORP /DE/, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.